Accendra HealthACH.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Accendra Health (ACH.N) trades at a negative P/E (-0.06x, due to a recent net loss), P/B of Negative, P/S of 0.01x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/S sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y).
Cross-sectional valuation: P/B percentile data for Accendra Health is still accumulating, both within its industry and across the broader market.
Shareholder return highlight: Total Shareholder Yield is 56.32%, ranking at the 100th percentile over the trailing 20Y window.
Shareholder returns here lean heavily on buybacks rather than cash dividends. Accendra Health operates in the Wholesale Trade sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: ACH · ACH
Want the full picture on whether Accendra Health (ACH.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | -0.06 | Negative | Negative | Negative | Negative | Negative | Negative |
| P/B (MRQ) | -0.03 | Negative | Negative | Negative | Negative | Negative | Negative |
| P/S (TTM) | 0.01 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 56.32% |